Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nesiritide: the clinical experience.

Literature DB >> 18629384

Nesiritide: the clinical experience.

Abstract

Nesiritide is an effective therapy in decreasing symptoms and left ventricular filling pressure in patients with acute decompensated heart failure. Health Canada has recently approved this agent for the management of this patient population. The clinical trials to date using nesiritide for the management of decompensated heart failure have been summarized. The clinical experience including indications for use, contraindications, dosage and monitoring has been reviewed. The following should serve as a general guide for the clinical use of nesiritide.

Entities: Disease Species

Mesh：

Substances：

Year: 2008 PMID： 18629384 PMCID： PMC2794444 DOI： 10.1016/s0828-282x(08)71025-0

Source DB: PubMed Journal: Can J Cardiol ISSN： 0828-282X Impact factor: 5.223

11 in total

1. Observation unit treatment of heart failure with nesiritide: results from the proaction trial.

Authors: W F Peacock; R Holland; R Gyarmathy; L Dunbar; M Klapholz; D P Horton; G de Lissovoy; C L Emerman
Journal: J Emerg Med Date: 2005-10 Impact factor: 1.484

2. Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial.

Authors: Ronald M Witteles; David Kao; Dianne Christopherson; Kelly Matsuda; Randall H Vagelos; Donald Schreiber; Michael B Fowler
Journal: J Am Coll Cardiol Date: 2007-10-23 Impact factor: 24.094

3. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.

Authors: Andrew J Burger; Darlene P Horton; Thierry LeJemtel; Jalal K Ghali; Guillermo Torre; George Dennish; Michael Koren; Jay Dinerman; Marc Silver; Mei L Cheng; Uri Elkayam
Journal: Am Heart J Date: 2002-12 Impact factor: 4.749

Review 4. Evaluation and monitoring of patients with acute heart failure syndromes.

Authors: Anju Nohria; Lisa M Mielniczuk; Lynne Warner Stevenson
Journal: Am J Cardiol Date: 2005-09-19 Impact factor: 2.778

5. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

Authors:
Journal: JAMA Date: 2002-03-27 Impact factor: 56.272

6. Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial).

Authors: Clyde W Yancy; Ajay Singh
Journal: Am J Cardiol Date: 2006-05-19 Impact factor: 2.778

7. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

Authors: W S Colucci; U Elkayam; D P Horton; W T Abraham; R C Bourge; A D Johnson; L E Wagoner; M M Givertz; C S Liang; M Neibaur; W H Haught; T H LeJemtel
Journal: N Engl J Med Date: 2000-07-27 Impact factor: 91.245

8. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial.

Authors: L S Marcus; D Hart; M Packer; M Yushak; N Medina; R S Danziger; D F Heitjan; S D Katz
Journal: Circulation Date: 1996-12-15 Impact factor: 29.690

9. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial.

Authors: Robert M Mentzer; Mehmet C Oz; Robert N Sladen; Allen H Graeve; Robert F Hebeler; John M Luber; Nicholas G Smedira
Journal: J Am Coll Cardiol Date: 2006-12-11 Impact factor: 24.094

10. Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial).

Authors: Clyde W Yancy; Mitchell T Saltzberg; Robert L Berkowitz; Barry Bertolet; Krishnaswami Vijayaraghavan; Kenneth Burnham; Ron M Oren; Kirk Walker; Darlene P Horton; Marc A Silver
Journal: Am J Cardiol Date: 2004-09-01 Impact factor: 2.778

1 in total

1. A rapid reporter assay for recombinant human brain natriuretic peptide (rhBNP) by GloSensor technology.

Authors: Lei Yu; Xinchang Shi; Chunmei Han; Chunming Rao; Junzhi Wang
Journal: J Pharm Anal Date: 2018-04-20

1 in total